id	sid	tid	token	lemma	pos
dz010p12h95	1	1	around	around	ADV
dz010p12h95	1	2	70	70	NUM
dz010p12h95	1	3	%	%	NOUN
dz010p12h95	1	4	of	of	ADP
dz010p12h95	1	5	breast	breast	NOUN
dz010p12h95	1	6	cancer	cancer	NOUN
dz010p12h95	1	7	tumors	tumor	NOUN
dz010p12h95	1	8	are	be	AUX
dz010p12h95	1	9	estrogen	estrogen	NOUN
dz010p12h95	1	10	receptor	receptor	NOUN
dz010p12h95	1	11	positive	positive	ADJ
dz010p12h95	1	12	(	(	PUNCT
dz010p12h95	1	13	er+	er+	NOUN
dz010p12h95	1	14	)	)	PUNCT
dz010p12h95	1	15	.	.	PUNCT
dz010p12h95	2	1	although	although	SCONJ
dz010p12h95	2	2	endocrine	endocrine	NOUN
dz010p12h95	2	3	therapies	therapy	NOUN
dz010p12h95	2	4	like	like	ADP
dz010p12h95	2	5	tamoxifen	tamoxifen	NOUN
dz010p12h95	2	6	and	and	CCONJ
dz010p12h95	2	7	fulvestrant	fulvestrant	NOUN
dz010p12h95	2	8	have	have	AUX
dz010p12h95	2	9	been	be	AUX
dz010p12h95	2	10	the	the	DET
dz010p12h95	2	11	mainstay	mainstay	NOUN
dz010p12h95	2	12	for	for	ADP
dz010p12h95	2	13	er+	er+	NOUN
dz010p12h95	2	14	breast	breast	NOUN
dz010p12h95	2	15	cancer	cancer	NOUN
dz010p12h95	2	16	patient	patient	NOUN
dz010p12h95	2	17	treatment	treatment	NOUN
dz010p12h95	2	18	,	,	PUNCT
dz010p12h95	2	19	about	about	ADV
dz010p12h95	2	20	33	33	NUM
dz010p12h95	2	21	%	%	NOUN
dz010p12h95	2	22	of	of	ADP
dz010p12h95	2	23	these	these	DET
dz010p12h95	2	24	patients	patient	NOUN
dz010p12h95	2	25	have	have	VERB
dz010p12h95	2	26	tumors	tumor	NOUN
dz010p12h95	2	27	that	that	PRON
dz010p12h95	2	28	eventually	eventually	ADV
dz010p12h95	2	29	relapse	relapse	VERB
dz010p12h95	2	30	and	and	CCONJ
dz010p12h95	2	31	develop	develop	VERB
dz010p12h95	2	32	as	as	ADP
dz010p12h95	2	33	recurrent	recurrent	ADJ
dz010p12h95	2	34	metastatic	metastatic	ADJ
dz010p12h95	2	35	tumors	tumor	NOUN
dz010p12h95	2	36	that	that	PRON
dz010p12h95	2	37	are	be	AUX
dz010p12h95	2	38	resistant	resistant	ADJ
dz010p12h95	2	39	to	to	PART
dz010p12h95	2	40	endocrine	endocrine	VERB
dz010p12h95	2	41	therapy	therapy	NOUN
dz010p12h95	2	42	.	.	PUNCT
dz010p12h95	3	1	the	the	DET
dz010p12h95	3	2	molecular	molecular	ADJ
dz010p12h95	3	3	mechanisms	mechanism	NOUN
dz010p12h95	3	4	of	of	ADP
dz010p12h95	3	5	endocrine	endocrine	NOUN
dz010p12h95	3	6	therapy	therapy	NOUN
dz010p12h95	3	7	resistance	resistance	NOUN
dz010p12h95	3	8	are	be	AUX
dz010p12h95	3	9	poorly	poorly	ADV
dz010p12h95	3	10	understood.our	understood.our	NUM
dz010p12h95	3	11	lab	lab	NOUN
dz010p12h95	3	12	identified	identify	VERB
dz010p12h95	3	13	the	the	DET
dz010p12h95	3	14	oncogene	oncogene	NOUN
dz010p12h95	3	15	and	and	CCONJ
dz010p12h95	3	16	transcription	transcription	NOUN
dz010p12h95	3	17	factor	factor	NOUN
dz010p12h95	3	18	znf217	znf217	NOUN
dz010p12h95	3	19	(	(	PUNCT
dz010p12h95	3	20	human)/zfp217	human)/zfp217	NOUN
dz010p12h95	3	21	(	(	PUNCT
dz010p12h95	3	22	mouse	mouse	NOUN
dz010p12h95	3	23	)	)	PUNCT
dz010p12h95	3	24	as	as	ADP
dz010p12h95	3	25	an	an	DET
dz010p12h95	3	26	er	er	INTJ
dz010p12h95	3	27	modulating	modulate	VERB
dz010p12h95	3	28	protein	protein	NOUN
dz010p12h95	3	29	which	which	PRON
dz010p12h95	3	30	drives	drive	VERB
dz010p12h95	3	31	tamoxifen	tamoxifen	NOUN
dz010p12h95	3	32	resistance	resistance	NOUN
dz010p12h95	3	33	in	in	ADP
dz010p12h95	3	34	vivo	vivo	PROPN
dz010p12h95	3	35	.	.	PUNCT
dz010p12h95	4	1	however	however	ADV
dz010p12h95	4	2	,	,	PUNCT
dz010p12h95	4	3	no	no	DET
dz010p12h95	4	4	studies	study	NOUN
dz010p12h95	4	5	have	have	AUX
dz010p12h95	4	6	described	describe	VERB
dz010p12h95	4	7	mechanistic	mechanistic	ADJ
dz010p12h95	4	8	information	information	NOUN
dz010p12h95	4	9	on	on	ADP
dz010p12h95	4	10	how	how	SCONJ
dz010p12h95	4	11	znf217	znf217	NOUN
dz010p12h95	4	12	causes	cause	VERB
dz010p12h95	4	13	tamoxifen	tamoxifen	NOUN
dz010p12h95	4	14	resistance	resistance	NOUN
dz010p12h95	4	15	.	.	PUNCT
dz010p12h95	5	1	ligand	ligand	NOUN
dz010p12h95	5	2	independent	independent	ADJ
dz010p12h95	5	3	activation	activation	NOUN
dz010p12h95	5	4	of	of	ADP
dz010p12h95	5	5	er	er	INTJ
dz010p12h95	5	6	by	by	ADP
dz010p12h95	5	7	growth	growth	NOUN
dz010p12h95	5	8	factor	factor	NOUN
dz010p12h95	5	9	signaling	signal	VERB
dz010p12h95	5	10	pathways	pathway	NOUN
dz010p12h95	5	11	is	be	AUX
dz010p12h95	5	12	a	a	DET
dz010p12h95	5	13	main	main	ADJ
dz010p12h95	5	14	mechanism	mechanism	NOUN
dz010p12h95	5	15	of	of	ADP
dz010p12h95	5	16	tamoxifen	tamoxifen	NOUN
dz010p12h95	5	17	resistance	resistance	NOUN
dz010p12h95	5	18	.	.	PUNCT
dz010p12h95	6	1	significantly	significantly	ADV
dz010p12h95	6	2	,	,	PUNCT
dz010p12h95	6	3	znf217	znf217	PROPN
dz010p12h95	6	4	directly	directly	ADV
dz010p12h95	6	5	activates	activate	VERB
dz010p12h95	6	6	the	the	DET
dz010p12h95	6	7	erbb3	erbb3	PROPN
dz010p12h95	6	8	/	/	SYM
dz010p12h95	6	9	pi3k	pi3k	NUM
dz010p12h95	6	10	/	/	SYM
dz010p12h95	6	11	akt	akt	NOUN
dz010p12h95	6	12	signaling	signal	VERB
dz010p12h95	6	13	pathway	pathway	NOUN
dz010p12h95	6	14	.	.	PUNCT
dz010p12h95	7	1	in	in	ADP
dz010p12h95	7	2	this	this	DET
dz010p12h95	7	3	study	study	NOUN
dz010p12h95	7	4	,	,	PUNCT
dz010p12h95	7	5	i	i	PRON
dz010p12h95	7	6	identified	identify	VERB
dz010p12h95	7	7	a	a	DET
dz010p12h95	7	8	novel	novel	NOUN
dz010p12h95	7	9	and	and	CCONJ
dz010p12h95	7	10	prognostic	prognostic	PROPN
dz010p12h95	7	11	znf217and	znf217and	PROPN
dz010p12h95	7	12	nrg1-(ligand	nrg1-(ligand	NOUN
dz010p12h95	7	13	of	of	ADP
dz010p12h95	7	14	erbb3	erbb3	PROPN
dz010p12h95	7	15	)	)	PUNCT
dz010p12h95	7	16	dependent	dependent	ADJ
dz010p12h95	7	17	gene	gene	NOUN
dz010p12h95	7	18	expression	expression	NOUN
dz010p12h95	7	19	signature	signature	NOUN
dz010p12h95	7	20	by	by	ADP
dz010p12h95	7	21	rna	rna	PROPN
dz010p12h95	7	22	-	-	PUNCT
dz010p12h95	7	23	seq	seq	PROPN
dz010p12h95	7	24	and	and	CCONJ
dz010p12h95	7	25	non	non	ADJ
dz010p12h95	7	26	-	-	ADJ
dz010p12h95	7	27	canonical	canonical	ADJ
dz010p12h95	7	28	er	er	INTJ
dz010p12h95	7	29	binding	bind	VERB
dz010p12h95	7	30	sites	site	NOUN
dz010p12h95	7	31	in	in	ADP
dz010p12h95	7	32	the	the	DET
dz010p12h95	7	33	genome	genome	NOUN
dz010p12h95	7	34	by	by	ADP
dz010p12h95	7	35	chip	chip	NOUN
dz010p12h95	7	36	-	-	PUNCT
dz010p12h95	7	37	seq	seq	NOUN
dz010p12h95	7	38	in	in	ADP
dz010p12h95	7	39	mcf7	mcf7	NOUN
dz010p12h95	7	40	cells	cell	NOUN
dz010p12h95	7	41	.	.	PUNCT
dz010p12h95	8	1	through	through	ADP
dz010p12h95	8	2	cut&run	cut&run	ADJ
dz010p12h95	8	3	sequencing	sequencing	NOUN
dz010p12h95	8	4	,	,	PUNCT
dz010p12h95	8	5	i	i	PRON
dz010p12h95	8	6	also	also	ADV
dz010p12h95	8	7	discovered	discover	VERB
dz010p12h95	8	8	erand	erand	PROPN
dz010p12h95	8	9	nrg1	nrg1	PROPN
dz010p12h95	8	10	-	-	PUNCT
dz010p12h95	8	11	dependent	dependent	ADJ
dz010p12h95	8	12	znf217	znf217	NOUN
dz010p12h95	8	13	binding	bind	VERB
dz010p12h95	8	14	sites	site	NOUN
dz010p12h95	8	15	in	in	ADP
dz010p12h95	8	16	the	the	DET
dz010p12h95	8	17	mcf7	mcf7	NOUN
dz010p12h95	8	18	genome	genome	NOUN
dz010p12h95	8	19	.	.	PUNCT
dz010p12h95	9	1	i	i	PRON
dz010p12h95	9	2	discovered	discover	VERB
dz010p12h95	9	3	transcriptomic	transcriptomic	ADJ
dz010p12h95	9	4	and	and	CCONJ
dz010p12h95	9	5	genomic	genomic	ADJ
dz010p12h95	9	6	changes	change	NOUN
dz010p12h95	9	7	that	that	PRON
dz010p12h95	9	8	promote	promote	VERB
dz010p12h95	9	9	lower	low	ADJ
dz010p12h95	9	10	survival	survival	NOUN
dz010p12h95	9	11	in	in	ADP
dz010p12h95	9	12	er+	er+	NOUN
dz010p12h95	9	13	breast	breast	NOUN
dz010p12h95	9	14	cancer	cancer	NOUN
dz010p12h95	9	15	patients	patient	NOUN
dz010p12h95	9	16	receiving	receive	VERB
dz010p12h95	9	17	tamoxifen	tamoxifen	NOUN
dz010p12h95	9	18	.	.	PUNCT
dz010p12h95	10	1	these	these	DET
dz010p12h95	10	2	data	datum	NOUN
dz010p12h95	10	3	identified	identify	VERB
dz010p12h95	10	4	key	key	ADJ
dz010p12h95	10	5	pathways	pathway	NOUN
dz010p12h95	10	6	altered	alter	VERB
dz010p12h95	10	7	in	in	ADP
dz010p12h95	10	8	a	a	DET
dz010p12h95	10	9	znf217	znf217	NOUN
dz010p12h95	10	10	-	-	PUNCT
dz010p12h95	10	11	dependent	dependent	ADJ
dz010p12h95	10	12	manner	manner	NOUN
dz010p12h95	10	13	after	after	ADP
dz010p12h95	10	14	nrg1	nrg1	PROPN
dz010p12h95	10	15	induction	induction	NOUN
dz010p12h95	10	16	.	.	PUNCT
dz010p12h95	11	1	through	through	ADP
dz010p12h95	11	2	integration	integration	NOUN
dz010p12h95	11	3	of	of	ADP
dz010p12h95	11	4	er	er	INTJ
dz010p12h95	11	5	chip	chip	NOUN
dz010p12h95	11	6	-	-	PUNCT
dz010p12h95	11	7	seq	seq	PROPN
dz010p12h95	11	8	&	&	CCONJ
dz010p12h95	11	9	amp	amp	PROPN
dz010p12h95	11	10	;	;	PUNCT
dz010p12h95	11	11	znf217	znf217	NOUN
dz010p12h95	11	12	cut&run	cut&run	ADJ
dz010p12h95	11	13	data	datum	NOUN
dz010p12h95	11	14	,	,	PUNCT
dz010p12h95	11	15	i	i	PRON
dz010p12h95	11	16	identified	identify	VERB
dz010p12h95	11	17	pck1	pck1	NOUN
dz010p12h95	11	18	and	and	CCONJ
dz010p12h95	11	19	phgdh	phgdh	PROPN
dz010p12h95	11	20	as	as	ADP
dz010p12h95	11	21	two	two	NUM
dz010p12h95	11	22	novel	novel	NOUN
dz010p12h95	11	23	inducers	inducer	NOUN
dz010p12h95	11	24	of	of	ADP
dz010p12h95	11	25	tamoxifen	tamoxifen	NOUN
dz010p12h95	11	26	resistance	resistance	NOUN
dz010p12h95	11	27	that	that	SCONJ
dz010p12h95	11	28	rewire	rewire	NOUN
dz010p12h95	11	29	metabolism	metabolism	NOUN
dz010p12h95	11	30	.	.	PUNCT
dz010p12h95	12	1	both	both	PRON
dz010p12h95	12	2	can	can	AUX
dz010p12h95	12	3	drive	drive	VERB
dz010p12h95	12	4	endocrine	endocrine	NOUN
dz010p12h95	12	5	therapy	therapy	NOUN
dz010p12h95	12	6	resistance	resistance	NOUN
dz010p12h95	12	7	in	in	ADP
dz010p12h95	12	8	cell	cell	NOUN
dz010p12h95	12	9	culture	culture	NOUN
dz010p12h95	12	10	.	.	PUNCT
dz010p12h95	13	1	pck1	pck1	NOUN
dz010p12h95	13	2	deficiency	deficiency	NOUN
dz010p12h95	13	3	reduces	reduce	VERB
dz010p12h95	13	4	tumor	tumor	NOUN
dz010p12h95	13	5	burden	burden	NOUN
dz010p12h95	13	6	in	in	ADP
dz010p12h95	13	7	vivo	vivo	PROPN
dz010p12h95	13	8	in	in	ADP
dz010p12h95	13	9	mouse	mouse	PROPN
dz010p12h95	13	10	pymt	pymt	PROPN
dz010p12h95	13	11	mammary	mammary	ADJ
dz010p12h95	13	12	cancer	cancer	NOUN
dz010p12h95	13	13	cells	cell	NOUN
dz010p12h95	13	14	±	±	PROPN
dz010p12h95	13	15	shrna	shrna	PROPN
dz010p12h95	13	16	pck1	pck1	PROPN
dz010p12h95	13	17	knockdown	knockdown	NOUN
dz010p12h95	13	18	.	.	PUNCT
dz010p12h95	14	1	significantly	significantly	ADV
dz010p12h95	14	2	,	,	PUNCT
dz010p12h95	14	3	tumor	tumor	NOUN
dz010p12h95	14	4	overexpression	overexpression	NOUN
dz010p12h95	14	5	of	of	ADP
dz010p12h95	14	6	pck1	pck1	PROPN
dz010p12h95	14	7	made	make	VERB
dz010p12h95	14	8	tumors	tumor	NOUN
dz010p12h95	14	9	resistant	resistant	ADJ
dz010p12h95	14	10	to	to	PART
dz010p12h95	14	11	tamoxifen	tamoxifen	VERB
dz010p12h95	14	12	,	,	PUNCT
dz010p12h95	14	13	while	while	SCONJ
dz010p12h95	14	14	the	the	DET
dz010p12h95	14	15	genetic	genetic	ADJ
dz010p12h95	14	16	and	and	CCONJ
dz010p12h95	14	17	pharmacological	pharmacological	ADJ
dz010p12h95	14	18	inhibition	inhibition	NOUN
dz010p12h95	14	19	of	of	ADP
dz010p12h95	14	20	pck1	pck1	PROPN
dz010p12h95	14	21	overcame	overcome	VERB
dz010p12h95	14	22	tamoxifen	tamoxifen	NOUN
dz010p12h95	14	23	resistance	resistance	NOUN
dz010p12h95	14	24	in	in	ADP
dz010p12h95	14	25	cell	cell	NOUN
dz010p12h95	14	26	culture	culture	NOUN
dz010p12h95	14	27	and	and	CCONJ
dz010p12h95	14	28	in	in	ADP
dz010p12h95	14	29	vivo.moreover	vivo.moreover	PROPN
dz010p12h95	14	30	,	,	PUNCT
dz010p12h95	14	31	by	by	ADP
dz010p12h95	14	32	analyzing	analyze	VERB
dz010p12h95	14	33	cell	cell	NOUN
dz010p12h95	14	34	culture	culture	NOUN
dz010p12h95	14	35	media	medium	NOUN
dz010p12h95	14	36	in	in	ADP
dz010p12h95	14	37	mcf7	mcf7	NOUN
dz010p12h95	14	38	cells	cell	VERB
dz010p12h95	14	39	±	±	PROPN
dz010p12h95	14	40	sirna	sirna	PROPN
dz010p12h95	14	41	znf217	znf217	PROPN
dz010p12h95	14	42	,	,	PUNCT
dz010p12h95	14	43	i	i	PRON
dz010p12h95	14	44	discovered	discover	VERB
dz010p12h95	14	45	that	that	SCONJ
dz010p12h95	14	46	znf217	znf217	NOUN
dz010p12h95	14	47	alters	alter	VERB
dz010p12h95	14	48	the	the	DET
dz010p12h95	14	49	cytokine	cytokine	NOUN
dz010p12h95	14	50	/	/	SYM
dz010p12h95	14	51	chemokine	chemokine	NOUN
dz010p12h95	14	52	/	/	SYM
dz010p12h95	14	53	growth	growth	NOUN
dz010p12h95	14	54	factor	factor	NOUN
dz010p12h95	14	55	profile	profile	NOUN
dz010p12h95	14	56	secreted	secrete	VERB
dz010p12h95	14	57	by	by	ADP
dz010p12h95	14	58	er+	er+	NOUN
dz010p12h95	14	59	breast	breast	NOUN
dz010p12h95	14	60	cancer	cancer	NOUN
dz010p12h95	14	61	cells	cell	NOUN
dz010p12h95	14	62	.	.	PUNCT
dz010p12h95	15	1	this	this	PRON
dz010p12h95	15	2	suggests	suggest	VERB
dz010p12h95	15	3	a	a	DET
dz010p12h95	15	4	role	role	NOUN
dz010p12h95	15	5	for	for	ADP
dz010p12h95	15	6	znf217	znf217	NOUN
dz010p12h95	15	7	in	in	ADP
dz010p12h95	15	8	modulating	modulate	VERB
dz010p12h95	15	9	the	the	DET
dz010p12h95	15	10	immune	immune	ADJ
dz010p12h95	15	11	cell	cell	NOUN
dz010p12h95	15	12	landscape	landscape	NOUN
dz010p12h95	15	13	in	in	ADP
dz010p12h95	15	14	the	the	DET
dz010p12h95	15	15	tumor	tumor	NOUN
dz010p12h95	15	16	microenvironment	microenvironment	NOUN
dz010p12h95	15	17	.	.	PUNCT
dz010p12h95	16	1	together	together	ADV
dz010p12h95	16	2	,	,	PUNCT
dz010p12h95	16	3	my	my	PRON
dz010p12h95	16	4	results	result	NOUN
dz010p12h95	16	5	suggest	suggest	VERB
dz010p12h95	16	6	that	that	SCONJ
dz010p12h95	16	7	zfp217	zfp217	NOUN
dz010p12h95	16	8	overexpression	overexpression	NOUN
dz010p12h95	16	9	in	in	ADP
dz010p12h95	16	10	er+	er+	NOUN
dz010p12h95	16	11	breast	breast	NOUN
dz010p12h95	16	12	cancer	cancer	NOUN
dz010p12h95	16	13	cells	cell	NOUN
dz010p12h95	16	14	causes	cause	VERB
dz010p12h95	16	15	endocrine	endocrine	NOUN
dz010p12h95	16	16	therapy	therapy	NOUN
dz010p12h95	16	17	resistance	resistance	NOUN
dz010p12h95	16	18	and	and	CCONJ
dz010p12h95	16	19	that	that	SCONJ
dz010p12h95	16	20	growth	growth	NOUN
dz010p12h95	16	21	factor	factor	NOUN
dz010p12h95	16	22	induction	induction	NOUN
dz010p12h95	16	23	via	via	ADP
dz010p12h95	16	24	nrg1	nrg1	PROPN
dz010p12h95	16	25	induces	induce	VERB
dz010p12h95	16	26	non	non	ADJ
dz010p12h95	16	27	-	-	ADJ
dz010p12h95	16	28	canonical	canonical	ADJ
dz010p12h95	16	29	er	er	INTJ
dz010p12h95	16	30	binding	bind	VERB
dz010p12h95	16	31	to	to	ADP
dz010p12h95	16	32	the	the	DET
dz010p12h95	16	33	genome	genome	NOUN
dz010p12h95	16	34	and	and	CCONJ
dz010p12h95	16	35	a	a	DET
dz010p12h95	16	36	znf217	znf217	NOUN
dz010p12h95	16	37	-	-	PUNCT
dz010p12h95	16	38	dependent	dependent	ADJ
dz010p12h95	16	39	gene	gene	NOUN
dz010p12h95	16	40	expression	expression	NOUN
dz010p12h95	16	41	signature	signature	NOUN
dz010p12h95	16	42	.	.	PUNCT
dz010p12h95	17	1	i	i	PRON
dz010p12h95	17	2	have	have	AUX
dz010p12h95	17	3	identified	identify	VERB
dz010p12h95	17	4	new	new	ADJ
dz010p12h95	17	5	targets	target	NOUN
dz010p12h95	17	6	that	that	PRON
dz010p12h95	17	7	are	be	AUX
dz010p12h95	17	8	regulated	regulate	VERB
dz010p12h95	17	9	by	by	ADP
dz010p12h95	17	10	znf217	znf217	PROPN
dz010p12h95	17	11	and	and	CCONJ
dz010p12h95	17	12	nrg1	nrg1	PROPN
dz010p12h95	17	13	signaling	signal	VERB
dz010p12h95	17	14	and	and	CCONJ
dz010p12h95	17	15	a	a	DET
dz010p12h95	17	16	possible	possible	ADJ
dz010p12h95	17	17	new	new	ADJ
dz010p12h95	17	18	role	role	NOUN
dz010p12h95	17	19	for	for	ADP
dz010p12h95	17	20	znf217	znf217	NOUN
dz010p12h95	17	21	in	in	ADP
dz010p12h95	17	22	regulating	regulate	VERB
dz010p12h95	17	23	the	the	DET
dz010p12h95	17	24	crosstalk	crosstalk	NOUN
dz010p12h95	17	25	between	between	ADP
dz010p12h95	17	26	er+	er+	NOUN
dz010p12h95	17	27	breast	breast	NOUN
dz010p12h95	17	28	cancer	cancer	NOUN
dz010p12h95	17	29	cells	cell	NOUN
dz010p12h95	17	30	and	and	CCONJ
dz010p12h95	17	31	immune	immune	ADJ
dz010p12h95	17	32	cells	cell	NOUN
dz010p12h95	17	33	.	.	PUNCT
dz010p12h95	18	1	this	this	DET
dz010p12h95	18	2	study	study	NOUN
dz010p12h95	18	3	unraveled	unravel	VERB
dz010p12h95	18	4	new	new	ADJ
dz010p12h95	18	5	mechanisms	mechanism	NOUN
dz010p12h95	18	6	of	of	ADP
dz010p12h95	18	7	endocrine	endocrine	NOUN
dz010p12h95	18	8	therapy	therapy	NOUN
dz010p12h95	18	9	resistance	resistance	NOUN
dz010p12h95	18	10	,	,	PUNCT
dz010p12h95	18	11	unveiling	unveil	VERB
dz010p12h95	18	12	new	new	ADJ
dz010p12h95	18	13	therapeutic	therapeutic	ADJ
dz010p12h95	18	14	options	option	NOUN
dz010p12h95	18	15	for	for	ADP
dz010p12h95	18	16	er+	er+	NOUN
dz010p12h95	18	17	breast	breast	NOUN
dz010p12h95	18	18	cancer	cancer	NOUN
dz010p12h95	18	19	patients	patient	NOUN
dz010p12h95	18	20	.	.	PUNCT